Programas de aceleración: EIT Health / Neotec/ AcexHealth

26 January, 2022

PTS Granada would like to invite you to the InfoDay for Entrepreneurs 2022 that will take place on February the 4th in Granada, at Fundación Parque Tecnológico de la Salud (PTS Granada).
We will introduce the EIT Health, Neotec and Acexhealth Acceleration programs.Those programs are unique offerings that give you the opportunity to learn new skills, connect with a vast network of experts, access new markets and finance and more. The acceleration InfoDay is a great opportunity to get answered any questions you may have about EIT Health, Neotec, and Acexhealth programs, help you finding the right program to accelerate your project and network with fellow entrepreneurs within the local ecosystem. Limnopharma will share its testimonial as participant in the three programs.

Agenda:
– 11:00 – 11:05 Welcome by Lourdes Nuñez (Parque Tecnológico de la Salud Granada)
– 11:05 – 11:45 Call for Entrepreneurs EIT Health 2022 – Joan Grasas (EIT Health Spain)
– 11:45 – 12:15 Call for Entreprises Neotec – Juan Luis Romera Santiago (CDTI)
– 12:15- 12:30 Call for Entreprises AcexHeath– Lourdes Núñez Müller (PTS Granada)
– 12:30 – 12:45 Testimonial with EIT Health/CDTI/Acexhealth – Juan Carlos Morales (Limno Pharma)- A start-up’s point of view
– 12:45 – 13:00 Testimonial with EIT Health/ Acexhealth – Todd Snowden (Ascent Business Advisors)- A mentor’s point of view
– 13:00 – 13:15 Q&A

REGISTRATION FOR THE MEETUP

Speakers
Joan Grasas is a healthtech entrepreneur and expert patient. By training, Joan is an engineer with a master in telecommunications, graduate in market research, and MBA within the internationalization programme of the Spanish Institute for Foreign Trade ICEX. He has co-founded three startups, has participated in different entrepreneur programmes, and mentors early-stage projects. As innovation and tech transfer manager, Joan has collaborated with several research institutes and SMEs of the biomedical industry.

Juan Carlos Morales has a PhD in Chemistry (Autonomous University of Madrid) and completed his education at the Universities of East Anglia, Alcalá, Sheffield, Rochester, Stanford, Institute of Organic Chemistry (belonging to the Spanish National Research Council, hereinafter “CSIC”) and Institute of Advanced Chemistry of Catalonia (CSIC). He has developed his professional career in the fields of Organic Chemistry and Biological Chemistry in both the public and private sectors. He began his professional career as Head of Chemistry at Puleva Biotech resuming academic research at the Spanish National Research Council (CSIC). He is currently a scientific researcher at the López Neyra Institute of Parasitology and Biomedicine (CSIC) and the author of more than 70 publications and 11 patents. Juan Carlos is a founding partner at Limnopharma and combines his professional activity with scientific guidance in the company, having participated in Neotec, EIT Health and AcexHealth.

Lourdes Núñez-Müller holds an MBA from IESE Business School, an Advanced Certificate for Executives in Management, Innovation and Technology from MIT Sloan School of Management and a Doctorate in Pharmacy from the University of Granada, Spain where she got her B.S. and M.S. in Pharmacy. She has been a PhD-level healthcare director in Sanitas (Madrid), CH -Werfen (Lexington, MA ,USA) and Biopharmaceutical Corporate Relations Liaison at the Dana-Farber Cancer Institute at Harvard Medical School (Boston, MA USA). After 5 years in Boston, she returned to Spain as Director of Knowledge Transfer, Internationalization and Entrepreneurship at PTS Granada. EIT Health & EIC Accelerator Evaluator. She has over 20 years of experience providing support for health companies.

Juan Luis Romera Santiago is Doctor in Chemistry with more than 15 years of experience in CDTI in management, promotion of the different financing instruments that CDTI has for R&D&I proposals, orientation and general advice within the different lines of action with special knowledge in Health, as well as representing CDTI in front of the different autonomous communities.

Todd Snowden Todd holds a BSc in Bioengineering and Pre-Medicine from The Catholic University of America (Washington, USA). Todd is a highly successful international healthcare executive with more than 30+ years’ experience in life sciences companies. He has worked in product management, global sales management and as CEO for companies in molecular diagnostics, laboratory services, and medical devices such as: W.L. Gore & Associates, Interleukin Genetics, and PathoGene. During 2010-2013, he was interim CEO at PathoGene, L.L.C, a start-up molecular diagnostics development company. Currently Todd is founder/principal of Ascent Business Advisors, a strategy consulting/interim management firm he founded in 2008 focused on clinical diagnostics, medical devices and digital health start-up companies.

Publicado en

Sin categorizar